Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir DF (GS-98-902) in Treatment-Experienced HIV
NCT00002415Phase 2Completed
- Sponsor
- Gilead Sciences
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Gilead Sciences. Status: completed.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002415.